1 PREVENTION RESEARCH ADVOCACY COMMUNITY PREPAREDNESS IN HIV PREVENTION TRIALS AND USE OF EXISTING METHODOLOGIES MDP 301 trial in Mwanza, Tanzania Charles.

Slides:



Advertisements
Similar presentations
What does sexual & reproductive health have to do with clinical trials? Providing contraception & reproductive health care helps.
Advertisements

Referral of participants for HIV follow-up care Africa Centre MDP experiences Presented by: Hlengiwe Ndlovu MDP Clinic coordinator.
1 How to organise & negotiate research collaborations David Ross MRC Tropical Epidemiology Group Infectious Disease Epidemiology Dep t, LSHTM January 2015.
Prevention of Mother to Child Transmission: A Panacea for an HIV- free Generation Mobilizing Community Members for Uptake of PMTCT Services: Approach and.
Contraceptive use and uptake Hasinah Asmal, Samantha Govender, Ian Naicker, Dinesh Singh, Gita Ramjee.
CDC Demonstration Project: Dallas County Jail Re-entry Project Klaus Kroyer Madsen Vice President, Programs From the Frontline: Public Health Institutes.
Uptake of HIV Related Care Among Seroconvertors— Implications for VOICE or future HIV prevention trials Sharika Gappoo*, Sarita Naidoo, Yuki Sookrajh,
From Research to Practice: Scale-up of Male Circumcision for HIV prevention in Tanzania Wambura Mwita National Institute for Medical Research Mwanza, Tanzania.
New Directions: Multimedia Connect Professor Susan Witte & Debbie Marcus.
California Senior Fall Prevention Coalitions Terri Restelli-Deits, MSW Area Agency on Aging Serving Napa and Solano CA Fall Prevention Summit / December.
Community Based Approaches: A review of intervention models and evidence of their effectiveness for preventing maternal-to-child transmission of HIV Joanna.
Forming and Sustaining Community Groups / Community Advisory boards (CWGs/CABs) Presenter: Smangaliso Ntshele Community Mobilization Project Leader, Medical.
Tathmini GBV: Evaluating Comprehensive Gender-Based Violence Program Scale-up in Tanzania Susan Settergren Futures Group.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
First Hand Perspective of working on a Microbicides Phase111 Trial Misiwe Mzimela: Social Science Coordinator at Africa Centre.
HIV/AIDS mainstreaming in the workplace: an experience of CSO’s Tanzania AIDS Forum HIV/AIDS Technical review meeting Blue Peal Hotel, Dar Es Salaam 30.
DCAC ©DCAC 2002 Organizing a Sustainable System of Care for Children with Asthma DC Asthma Coalition Lisa A. Gilmore, Project Director
HIV Prevention Trials Network Update Africa Regional Working Group 20 May 2003.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
The Role of the School in Health, Learning and Development in Low Income Countries Lesley Drake, Coordinator.
DEPARTMENT OF STUDENT, FAMILY AND COMMUNITY SERVICES Leadership I and II February, 2011 Providing Services to Students, Families and Community through.
Community Issues And Needs Associated With Microbicides Clinical Trials Presenter: John M. Mutsambi, Community Liaison Officer with University of Zimbabwe.
Global Campaign for Microbicides Rebekah Webb, European Coordinator
New York State Diabetes Campaign Overview Deborah Zahn, MPH Deputy Director.
PREVALENCE OF ANAEMIA IN WOMEN AT SCREENING AND FOLLOW-UP IN A MICROBICIDE PHASE III TRIAL Hasinah Asmal, Dinesh Singh, Gita Ramjee HIV Prevention Research.
Community Engagement in clinical trials Projet Ubuzima experience By Marie Michèle UMULISA Community Outreach & Recruitment Manager, Projet Ubuzima.
What Makes a Successful Trial? MorenikeUkpong Nigeria HIV Vaccine and Microbicide Advocacy Group.
Good Participatory Practice UNAIDS & AVAC Document Pauline Irungu Global Campaign for Microbicides.
MDP301 An international multi-centre, randomised, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 0.5% and 2% PRO 2000/5.
WHO European Ministerial Conference on Couteracting Obesity European Commission Workshop About Shape Up.
Background Study Objectives Poster No. B50 Track 2  Family planning affects women’s health and lives, and depends on a variety of socio-demographic and.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
Historical development ICC-TB recommends creating a Partnership in meeting, Sept 2004 WHO signed co-funding agreement with Federation Red Cross, Aug 2006.
Group 1: HIV PREVENTION Facilitators: Ms Mai Harper Dr Stephen Kusasira.
CTxCPCRN Central Texas Cancer Prevention and Control Research Network Kick Off Grantee Meeting Atlanta, Georgia October 15-16, 2009.
“DEFENDING THE WEAK” DEPARTMENT OF COMMUNITY SAFETY AND LIAISON Build A United Front Against Crime PROVINCIAL SYMPOSIUM Resolutions 21 January 2010, Durban.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Module 4: Using the PMTCT Checklists, Guides, Forms, and Video.
Building a Microbicides Movement Partnerships in advocacy and science. Global Campaign for Microbicides.
Access to Care and Treatment in Microbicide Trials: Findings from the SOC Mapping Exercise Sean Philpott, PhD, MSBioethics Science.
Overview of Microbicide Trials Issues and Challenges.
AN INTERNATIONAL MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF 0.5% AND 2% PRO 2000/5 GELS FOR.
1 MODULE III Orientation to the UCEDD. 2 Topics of Presentation 1. Orientation to the UCEDD 2. Themes of the DD Act 3. Core Functions 4. Areas of Emphasis.
Module 2: Learning Objectives
HOW ARE MDP PREPARING COMMUNITIES AT TRIAL SITES? MDP301.
From the Ground Up: The Case of Integrating Family Planning and HIV/AIDS Services in Tanzania Integrated Approaches, Local Answers Presenter: Ms. Christine.
Universal Services Anthony Mohammed Adult Services Department January 2010.
Working Synergistically: Two Possible Mechanisms.
Ensuring Adherence and Retention to HIV Care and Treatment among Orphans and Vulnerable Children A Multi-Country Experience Thebisa Chaava MPH Senior Technical.
PROJECT IN-CARE Chicago’s Positive Charge Project Roman Buenrostro, AIDS Foundation of Chicago Sunday July 22, 2012.
Institutional Initiatives Action Plans Town Hall Meeting April 16, 2007.
University of Kentucky Center for Clinical and Translational Science (CCTS) November 2015 Stephen W. Wyatt, DMD, MPH Senior Associate Director Center for.
Intravaginal practices in a cohort of women at high risk in North-West Tanzania: Baseline associations with HIV Suzanna Francis, Tony Ao, Joseph Chilongani,
AN INTERNATIONAL MULTI-CENTRE, RANDOMISED, DOUBLE- BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF 0.5% AND 2% PRO 2000 GELS FOR.
Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority? November 2009, dar Es Salaam.
Country and community preparedness: Community Involvement in Clinical Trials Global Campaign for Microbicides.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
International Partnership for Microbicides Approach to HIV Treatment and Care in Future IPM Microbicide Trials Pam Norick, Chief of External Relations.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
Phase III Microbicide Trials Update Dr. Lut Van Damme IAS Conference Sydney, Australia July 2007.
Resource Review for Teaching Resource Review for Teaching Victoria M. Rizzo, LCSW-R, PhD Jessica Seidman, LMSW Columbia University School of Social Work.
Peer Education Plus (PEP) Model; A Veritable Tool for achieving Behaviour Change. Experience from a Rural Community In Kaduna State, Nigeria AUTHORS: P.
SLIDE 1 MARIE STOPES TANZANIA Integrated RH services for youth NATIONAL FAMILY PLANNING MCH / HIV STAKEHOLDERS MEETING GIRRAFE HOTEL, DAR ES SALAAM SEPTEMBER.
Impact of level of researcher support on coital diary results and acceptability among women at high risk of HIV in the Microbicides Development Programme.
GCM Community Involvement Tool Kit Glenburn Lodge, Muldersdrift, South Africa November 27-28, 2007.
Firma A. Kisika 1, Duncun Ndimbo 1, Rhoda Kunzugala 2, Richard Mkinga 3, Nolasco Ngoloka 2,, DMOs& DCDOs Iringa 1, Kilolo 2 and Mbinga 3 District Councils.
Health Promotion & Aging
How informed is consent
New Prevention Technologies Workshop Module 4: Who’s Who
The Community Involvement Community of Practice: A Model for Collaboration in the Field Katherine West Slevin1, Nomampondo Barnabas2, Stella Kirkendale3,
Presentation transcript:

1 PREVENTION RESEARCH ADVOCACY COMMUNITY PREPAREDNESS IN HIV PREVENTION TRIALS AND USE OF EXISTING METHODOLOGIES MDP 301 trial in Mwanza, Tanzania Charles Shagi Winner of the “2010 Omololu Falobi award for excellence in HIV prevention research community advocacy”

Context Microbiocide Development Programme (MDP)known as MDP 301 was a multi-centre, randomised, double blind, placebo controlled phase-III trial took place , preceded by a 2-yr feasibility study funded by (DFID) & the UK Medical Research Council (MRC) 2

Cont.. In Tanzania, Zambia, Uganda and S/Africa Engaged a number of African/Europe research institutions- for Tanzania was mainly AMREF, NIMR and LSTHM AMREF participated mainly in clinical recruitment, follow-up and community engagement 3

Cont… Mwanza City, Northern Tanzania was one of the study sites recruited 1146 women working in bars, hotels, guest houses, food/ recreational facilities as occupational cohort MDP 301 results were released in 2009 “HIV ‘prevention’ gel PRO 2000 proven ineffective”. More information about the MDP 301 microbicides trial can be found at 4

Community Liaison System [CLS] CLS was established as a main component to the trial (additional to the basic ones e.g. clinical team, data monitor) Enabled effective communication among community stakeholders – Trial participants (had elected their leaders) – health service providers – Local government and community leaders –Other stakeholders 5

6 Community preparation requires a variety of tools, mechanisms and strategies to facilitate authentic partnerships between communities and researchers including providing a user- friendly project name Branded as ‘MWAMKO’ extracted from swahili: ‘mwanamke amua kuhusu maisha yako CLS …

CLS.. cont CLS persisted throughout during the trial and post-trial period Functioned in 10 administrative wards of Mwanza city Participants were invited for screening at mobile clinics those eligible got enrolled to the trial for the duration of 52 weeks. 7

8 CLS used extensive participatory approaches and processes - Participatory Rural Appraisal - Participatory learning & actions Stakeholders Advisory Group (SAG) CLS Community Advisory Committee (CAC) formed by participants’ representatives Participation of stakeholders improved referrals and link for trial participants Community participation

Participatory mapping identified geographical clusters of bars, restaurants and other facilities that became the foundation for community representation and participation in Mwanza

advantages of CLS Improved understanding of the objectives of the trial and anticipated results Allowed moral support, interactions, sharing and address challenges jointly Promoted male partner involvement Increased access to other services –HIV counseling and testing –Family planning –STI management –Referral to CTC for those tested HIV+ 10

VIDEO 11

12

Conclusion Community Liaison System remains a very crucial component in clinical trials, promotes study adherence & preparations for study outcome (retention in MWAMKO was 80%) Study participants are proud of being part of research 13

14 AKNOWLEDGEMENTS.Communities participating in prevention research.AMREF/NIMR/LSHTM collaboration in Tanzania.MDP 301 trial sites staff and leadership.COP (Community of Practices) forums.GCM (Global Campaign for Microbicides).AMAG (African Microbicides Advocacy Group).AVAC (Global Advocacy for HIV prevention) ASANTENI SANA